AU Patent

AU2014256229B2 — 19-nor C3,3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

Assigned to Sage Therapeutics LLC · Expires 2018-10-04 · 8y expired

What this patent protects

Provided herein are 19-nor C3,3-disubstituted C21-pyrazolyl steroids of Formula (I), and pharmaceutically acceptable salts thereof; wherein-, R

USPTO Abstract

Provided herein are 19-nor C3,3-disubstituted C21-pyrazolyl steroids of Formula (I), and pharmaceutically acceptable salts thereof; wherein-, R

Drugs covered by this patent

Patent Metadata

Patent number
AU2014256229B2
Jurisdiction
AU
Classification
—
Expires
2018-10-04
Drug substance claim
No
Drug product claim
No
Assignee
Sage Therapeutics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.